Editors' ChoiceObesity

Targeting ASXL2 in macrophages: An antidote to adiposity?

See allHide authors and affiliations

Science Translational Medicine  20 May 2020:
Vol. 12, Issue 544, eabb7099
DOI: 10.1126/scitranslmed.abb7099

Abstract

Myeloid-specific Asxl2 deletion renders mice resistant to high-fat diet–induced obesity and related complications by regulating brown adipose tissue.

View Full Text

Stay Connected to Science Translational Medicine